These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Investigating the potential of statin medications as a nitric oxide (NO) release agent to decrease decompression sickness: a review article. Duplessis CA; Fothergill D Med Hypotheses; 2008; 70(3):560-6. PubMed ID: 17855002 [TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering. Marzilli M Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728 [TBL] [Abstract][Full Text] [Related]
7. Statins and the endothelium. Ii M; Losordo DW Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035 [TBL] [Abstract][Full Text] [Related]
8. The effects of statins on endothelium, inflammation and cardioprotection. Elrod JW; Lefer DJ Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478 [TBL] [Abstract][Full Text] [Related]
9. Potential vascular benefits of statins. Kinlay S Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810 [TBL] [Abstract][Full Text] [Related]
10. [The pleiotropic effects of statins]. Wolfovitz E Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158 [TBL] [Abstract][Full Text] [Related]
11. Antioxidative effects of statins. Adam O; Laufs U Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762 [TBL] [Abstract][Full Text] [Related]
12. Novel therapies targeting the endothelium in sickle cell disease. Hoppe CC Hemoglobin; 2011; 35(5-6):530-46. PubMed ID: 21910600 [TBL] [Abstract][Full Text] [Related]
13. Statins: a treatment option for chronic heart failure? von Haehling S; Okonko DO; Anker SD Heart Fail Monit; 2004; 4(3):90-7. PubMed ID: 15772704 [TBL] [Abstract][Full Text] [Related]
14. Thrombosis and sickle cell disease. De Franceschi L; Cappellini MD; Olivieri O Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857 [TBL] [Abstract][Full Text] [Related]
15. Statins and cardioprotection--more than just lipid lowering? Ludman A; Venugopal V; Yellon DM; Hausenloy DJ Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042 [TBL] [Abstract][Full Text] [Related]
16. A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Hoppe C; Kuypers F; Larkin S; Hagar W; Vichinsky E; Styles L Br J Haematol; 2011 Jun; 153(5):655-63. PubMed ID: 21477202 [TBL] [Abstract][Full Text] [Related]
17. [Statins and endothelial dysfunction]. Filip-Ciubotaru FM; Manciuc C; Foia L Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):975-83. PubMed ID: 20191862 [TBL] [Abstract][Full Text] [Related]
18. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes]. Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071 [TBL] [Abstract][Full Text] [Related]
19. [Statins: possibly more than just lowering of the lipid level]. Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742 [TBL] [Abstract][Full Text] [Related]